Data analysis skills
1. Nephrologist, Attending physician for the Cardiovascular Center, University of Miami Hospital and Clinic, Jackson Memorial Medical Center 2003
2. Development and implementation of the University of Miami Cedars Medical Center Dialysis and Plasmapheresis Service 2003
3. Development and implementation of the University of Miami, Interventional Nephrology Program, 2001
4. Medical Director for Outpatient Dialysis Services at Gambro North Miami 20003-2005
5. Development and implementation of the Fort Lauderdale Access Center, Medical Director 2008-2009
6. Development and Implementation of the Nephrology Service at Major Hospital, Shelbyville, IN 2010-2019
7. Founder, Medical Director of INDY VITAL 2019-2021
1. American Society of Diagnostic and Interventional Nephrology
2. American Society of Nephrology
3. American Medical Association
4. American College of Physicians
5. Indiana State Medical Association, 2010
Ultrasonography by Emory University
1. Juried or refereed journal articles and exhibitions, publications and abstracts Metabolic Acidosis with Extreme Elevation of Anion Gap: Case Report and Literature Review, The American Journal of Medical Sciences, Jan. 1999; Vol. 317, Number 1:38-49
2. Nefrologia Intervencionista: Ficção ou Realidade? Cristóvão F. Vieira, Arif Asif, Patricia Byers, Maria Claudia Vieira, Donna Merrill, Renne Hogan David Roth, Marcos Alexandre Vieira, Carlos Alberto Rost, José Aluisio Vieira.JBN 2004;26(3):129-136
3. Arif Asif, Jan Tawakol, Tasnim Khan, Cristovao F. Vieira, Patricia Byers, Florin Gadalean, Rene Hogan, Donna Merrill, and David Roth: Modification of the Peritoneoscopic Technique of Peritoneal Dialysis Catheter Insertion: Experience of an Interventional Nephrology Program, Sem in Dial. 2004
4. ASIF Arif ; BYERS Patricia ; VIEIRA Cristovao F. ; MERRILL Donna ; GADALEAN Florin ; BOURGOIGNIE Jacques J. ; LECLERCQ Baudouin ; ROTH David ; GADALLAH Merit F.: Peritoneoscopic placement of peritoneal dialysis catheter and bowel perforation: Experience of an interventional nephrology program, American journal of kidney diseases
5. Asif A, Byers P, Roth D, Vieira C: Developing a comprehensive diagnostic and interventional nephrology program at an academic center. Am J Kidney Dis. Asif A, Byers P, Preston RA, Vieira C et al: Diagnostic and Interventional Nephrology. Am J Kidney Dis. 2002
6. Asif A, Byers P, Vieira C et al: Peritoneal dialysis (PD) access: Experience of an Academic Interventional Nephrology (IN) Program. JASN 13; 393, 2002.
7. Asif A, Byers P, Vieira C et al: Choice of peritoneal dialysis and catheter insertion in the setting of a catastrophic start: Impact of an Interventional Nephrology Team. JASN 13; 393, 2002. Asif A, Byers P, Gadalean F, Hogan R, Pennell P, Roth D, Vieira C: Interventional Nephrology (IN): An Emerging Specialty of Nephrology. JASN 13; 401, 2002.
8. Asif A, Gadalean F, Hogan R, Reich J. N., Roth D, Saigal K, Vieira C: Ultrasonography by the Nephrologist. JASN 13; 457, 2002
9 . Asif A, Gadalean F, Hogan R, Rao V, Roth D, Saigal K, Vieira C: Renal Allograft Biopsy as an Outpatient Procedure. JASN 13; 457, 2002
1. Interventional Nephrology; PD Access Procedure Program at an Academic Center. Poster presentation. ASN Philadelphia, 2002
2. Interventional Nephrology (IN): An Emerging Specialty of Nephrology. Poster Presentation. ASN Philadelphia, 2002
3. Catastrophic Start and the Choice of Peritoneal Dialysis and Catheter Insertion: Impact of an Interventional Nephrology Team. Poster Presentation. ASN Philadelphia, 2002
4. Ultrasonography by the Nephrologist. Poster Presentation. ASN Philadelphia, 2002
5. Renal Allograft Biopsy as an Outpatient Procedure. Poster presentation. ASN Philadelphia, 2002
6. Long Term Survival of 122 Patients with Lupus Nephritis. Poster Presentation. ASN Philadelphia, 2002
1. Principal Investigator: A prospective, randomized, double-blind, double-dummy, forced-titration, multicenter, parallel group, one year treatment trial to compare MICARDIS (telmisartan) 80 mg versus COZAAR (losartan) 100 mg, in hypertensive type 2 diabetic patients with overt nephropathy (AMADEO study).
2. Sub-Investigator with Jorge Diego, M.D., Principal Investigator: A Phase 3 Study to Assess the Efficacy and Safety of an Oral Calcimimetic (AMG 073) in Secondary Hyperparathyroidism of End Stage Renal Disease Treated with Hemodialysis – Amgen Protocol No. AMG 073 20000172, 2002
3. Sub-Investigator with Jorge Diego, M.D., Principal Investigator: Correction of Hemoglobin and Outcomes in Renal Insufficiency (CHOIR) – Ortho Biotech Products, L.P. – Protocol No.: PR00-06-014, 2002
4. Sub-Investigator with J. Phillip Pennell, M.D., Principal Investigator: A Study of Renagel® Phosphate Binder Versus Calcium-Based Phosphate Binders in Hemodialysis Patients – Geltex Pharmaceuticals, Inc. – Protocol # GTC-68-401, 2002
5. Sub-Investigator with Jorge Diego, M.D., Principal Investigator: A Study of Darbepoetin alfa Administered Once Every Four Weeks in Chronic Renal Insufficiency (CRI) Subjects with Anemia – Amgen Protocol No.: 20010212
6. Sub-Investigator with Jorge Diego, M.D., Principal Investigator: A Placebo-controlled, Double-blind, Extension Study to Assess the Long-term Safety of an Oral Calcimimetic(AMG 073) in Secondary Hyperparathyroidism of End Stage Renal Disease – Amgen Protocol No.: AMG 073 20010240, 2002Sub-Investigator with J. Phillip Pennell, M.D.,
7. Principal Investigator: A Study to Evaluate the Efficacy and Safety of 7.5% Icodextrin Peritoneal Dialysis Solution as Compared to Dianeal PD-2 Peritoneal Dialysis Solution with 4.25% Dextrose, for the Long Dwell in Patients treated with Automated Peritoneal Dialysis (APD) – Baxter Healthcare Corporation Protocol No.: RD-00-CA-050
2003-2004 Excellence in Teaching – Honor presented by the University of Miami Medical School
2004-2005 Excellence in Teaching – Honor presented by the University of Miami Medical School